样式: 排序: IF: - GO 导出 标记为已读
-
The efficacy of zuranolone versus placebo in postpartum depression and major depressive disorder: a systematic review and meta-analysis Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-03-15 Mackenzie Winslow, Emily White, Suzanne J. Rose, Elijah Salzer, Eric C. Nemec
-
Implementation of medication reviews in community pharmacy: reaching consensus on stakeholders’ recommendations for mechanisms of change using the nominal group technique Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-03-15 Dorothee E. Michel, Antonella P. Tonna, Dorothee C. Dartsch, Anita E. Weidmann
-
A qualitative study exploring the challenges and enablers of pharmacists with a recent background in community pharmacy transitioning into primary care Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-03-13 Ian Campbell, Heather Harrison, Amanj Kurdi
-
Availability, price, and affordability of anti-hepatitis B virus drugs: a cross-sectional study in China Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-03-12
Abstract Background The global prevalence of hepatitis B virus (HBV) has presented a persistent challenge for public health prevention and treatment. However, studies that assess the public's access to anti-HBV drugs are absent. Aim To examine the availability, pricing, and affordability of anti-HBV drugs in Jiangsu province, China and provide recommendations for improvement. Method An enhanced methodology
-
Artificial intelligence in academic writing and clinical pharmacy education: consequences and opportunities Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-03-12
Abstract The current academic debate on the use of artificial intelligence (AI) in research and teaching has been ongoing since the launch of ChatGPT in November 2022. It mainly focuses on ethical considerations, academic integrity, authorship and the need for new legal frameworks. Time efficiencies may allow for more critical thinking, while ease of pattern recognition across large amounts of data
-
A case–control study on the clinical characteristics of granisetron-related arrhythmias and the development of a predictive nomogram Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-28
Abstract Background Automatic monitoring and assessment are increasingly employed in drug safety evaluations using hospital information system data. The increasing concern about granisetron-related arrhythmias requires real-world studies to improve our understanding of its safety. Aim This study aimed to analyze the incidence, clinical characteristics, and risk factors of granisetron-related arrhythmias
-
Unveiling the future: precision pharmacovigilance in the era of personalized medicine Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-28 Lurdes Silva, Teresa Pacheco, Emília Araújo, Rita J. Duarte, Inês Ribeiro-Vaz, Renato Ferreira-da-Silva
In the era of personalized medicine, pharmacovigilance faces new challenges and opportunities, demanding a shift from traditional approaches. This article delves into the evolving landscape of drug safety monitoring in the context of personalized treatments. We aim to provide a succinct reflection on the intersection of tailored therapeutic strategies and vigilant pharmacovigilance practices. We discuss
-
Cost-effectiveness analysis of PD-1 inhibitors as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma in China: an economic evaluation based on network meta-analysis Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-26 Shuang Liu, Linbo Zhao, Fenghao Shi, Liping Kuai, Ruizhe Liu, Jianhua Tang
-
Pharmaceutical care for visually impaired patients: a qualitative study of community pharmacists' needs and professional experience Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-26 Théodora Merenda, Jennifer Denis, Stéphanie Patris
-
A cohort study comparing pharmacist activities during participation in general medical ward rounds: telehealth versus in-person during the COVID-19 pandemic Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-17 Meng Yap, Gail Edwards, Harry Gibbs, Harvey Newnham, Nicole Hancock, Erica Y. Tong
Background The COVID-19 pandemic created systemic challenges in patient care delivery. Aim To evaluate the impact on pharmacist activities during pharmacist participation in ward rounds via telehealth, compared to physical attendance. Method A single-centre, retrospective cohort study conducted from 18th Aug through 26th Oct 2020. Patients admitted to COVID and non-COVID general medical teams were
-
Antipsychotic prescribing and drug-related readmissions in multimorbid older inpatients: a post-hoc analysis of the OPERAM population Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-17 A. Bienfait, J. Lagreula, M. R. Blum, N. Rodondi, B. T. G. M. Sallevelt, W. Knol, D. O’Mahony, A. Spinewine, B. Boland, O. Dalleur
-
A cross-sectional survey of viral hepatitis education within pharmacy curricula in the United States Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-14 Michelle T. Martin, Aileen N. Pham, Jessica S. Wagner
-
Intervention for a correct medication list and medication use in older adults: a non-randomised feasibility study among inpatients and residents during care transitions Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-10 Ahmed Al Musawi, Lina Hellström, Malin Axelsson, Patrik Midlöv, Margareta Rämgård, Yuanji Cheng, Tommy Eriksson
-
Whole blood thiamine, intravenous thiamine supplementation and delirium occurrence in the intensive care unit: retrospective cohort analyses Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-08 Muhammad A. Mumin, Cathrine A. McKenzie, Valerie J. Page, Daniel Hadfield, Leanne M. Aitken, Fraser Hanks, Emma Cunningham, Bronagh Blackwood, Edwin Van Dellen, Arjen J. C. Slooter, Michael P. W. Grocott, Daniel F. McAuley, Peter E. Spronk
Background Thiamine di-phosphate is an essential cofactor in glucose metabolism, glutamate transformation and acetylcholinesterase activity, pathways associated with delirium occurrence. We hypothesised that a deficiency in whole blood thiamine and intravenous thiamine supplementation could impact delirium occurrence. Aim To establish whether a deficiency in whole blood thiamine and/or intravenous
-
Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-08 Francesca Wirth, Cathal A. Cadogan, Daniela Fialová, Ankie Hazen, Monika Lutters, Vibhu Paudyal, Anita E. Weidmann, Betul Okuyan, Martin C. Henman
Publishing in reputable peer-reviewed journals is an integral step of the clinical pharmacy research process, allowing for knowledge transfer and advancement in clinical pharmacy practice. Writing a manuscript for publication in a journal requires several careful considerations to ensure that research findings are communicated to the satisfaction of editors and reviewers, and effectively to the readers
-
Pharmacists working in residential aged care: a survey of pharmacist interest and perceived preparedness Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-05
Abstract Background Pharmacists involvement in residential aged care facilities has traditionally been limited to that of an external contractor providing medication reviews, or medication supply. Aim To explore Australian pharmacists’ interest and perceived preparedness to work as on-site pharmacists in residential aged care. Method National cross-sectional anonymous online survey open for two weeks
-
First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-05 Kenneth L. McCall, Bennett J. Doughty, Brian J. Piper, Heeral Naik, Seraphine Bange, Emily E. Leppien
-
Effects of inpatient creatinine testing frequency on acute kidney injury identification and staging: a historical cohort study Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-05
Abstract Background Acute kidney injury (AKI) is a multifactorial condition often induced by drugs commonly used in hospitals. Identifying and staging AKI necessitates frequent monitoring of renal function. Aim To assess the impact of real-world hospital practices regarding serum creatinine (SCr) testing on the identification and staging of AKI, and its implications for adjusting drug doses. Method
-
Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-02-05 Mégane Jermini, Caroline Fonzo-Christe, Katherine Blondon, Christelle Milaire, Jérôme Stirnemann, Pascal Bonnabry, Bertrand Guignard
-
Correction: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-01-25 Yuying Cui, Yingxue Guo
-
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-01-24
Abstract Background Semaglutide, liraglutide and tirzepatide are glucagon-like peptide-1 (GLP-1) receptor agonists that are effective for weight reduction. Recent reports of patients experiencing suicidal thoughts and other psychiatric adverse events while using GLP-1 agonists have raised concerns about the potential risk of self-harm and led the European Medicines Agency to investigate these medications
-
Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-01-20 Yibei Zhao, Huiming Jiang, Lifen Xue, Mi Zhou, Xiaobing Zhao, Fei Liu, SongJiang Jiang, Jing Huang, Long Meng
-
Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-01-20 Sha Zhang, Yidong Wang, Zhan Qi, Shanshan Tong, Deqiu Zhu
-
Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-01-19 Martin Luke Canning, Michael Barras, Ross McDougall, Stephanie Yerkovich, Ian Coombes, Clair Sullivan, Karen Whitfield
Background Clinical pharmacy quality indicators are often non-uniform and measure individual activities not linked to outcomes. Aim To define a consensus agreed pharmaceutical care bundle and patient outcome measures across an entire state health service. Method A four-round modified-Delphi approach with state Directors of Pharmacy was performed (n = 25). They were asked to rate on a 5-point Likert
-
A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-01-19 Tatsuaki Takeda, Shiho Sugimoto, Jun Matsumoto, Naohiro Iwata, Akihiko Nakamoto, Aya Fukuma Ozaki, Hirofumi Hamano, Noritaka Ariyoshi, Yoshito Zamami
-
Comparison of the sensitivities of pharmacotherapy-related and disease-specific quality of life measures in response to pharmacist-led pharmaceutical care for cancer outpatients: a randomised controlled trial Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-01-19 Phantipa Sakthong, Porntip Soipitak, Win Winit-Watjana
-
Communication skills-based training about medication switch encounters: pharmacy staff and patients’ experiences Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-01-17 Laura Schackmann, Ellen S. Koster, Liset van Dijk, Marcia Vervloet, Mette Heringa
-
Barriers to person-centered service design in pharmacy practice: examples, lessons, and potential solutions Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-01-09 Logan T. Murry, Shane P. Desselle
Despite increased attention to, and frameworks conceptualizing person-centered care, systematic, organizational, and provider-level barriers continue to discourage the development and delivery of person-centered care (PCC) in pharmacy practice and beyond. This commentary describes existing pharmacy-specific literature related to PCC, barriers to PCC within the context of pharmacy practice, and potential
-
The clinical and economic evidence of the management of urinary tract infections by community pharmacists in women aged 16 to 65 years: a systematic review Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-01-09 Ansonette Swart, Shalom I. Benrimoj, Sarah Dineen-Griffin
-
Application of behavioural theories, models, and frameworks in pharmacy practice research based on published evidence: a scoping review Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-01-04 Zachariah Nazar, Lina Mohammad Naseralallah, Derek Stewart, Vibhu Paudyal, Laila Shafei, Anita Weidmann
-
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2024-01-02 Pei Zhang, Lingli Zhang, Kai Xu, Yingtao Lin, Rui Ma, Mengdie Zhang, Xin Li
-
Comparison of the incidence of nausea and vomiting between linezolid and vancomycin using claims database: a retrospective cohort study Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-12-29 Takezo Tsutsumi, Shungo Imai, Kenji Momo, Hitoshi Kashiwagi, Yuki Sato, Mitsuru Sugawara, Yoh Takekuma
-
Screening for atrial fibrillation in care homes using pulse palpation and the AliveCor Kardia Mobile® device: a comparative cross-sectional pilot study Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-12-27 V. Savickas, A. J. Stewart, V. J. Short, A. Mathie, S. K. Bhamra, E. L. Veale, S. A. Corlett
-
Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-12-27
Abstract Background Patients often require adjustments to drug doses due to impaired renal function. Glomerular filtration rate (GFR) estimation using various equations can result in discrepancies, potentially leading to different dose adjustment recommendations. Aim To determine the clinical significance of discrepancies observed between different equations used to estimate GFR for drug dose adjustments
-
Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-12-27
Abstract Background The causality assessment tool can be utilized to assist patients in identifying adverse drug reactions (ADRs). Aim To evaluate the accuracy of the causality assessment tool for patients identifying ADRs compared to assessments made by pharmacists, and to explore how patients recall and recognize symptoms as ADRs. Method Mixed methods study consisting of self-administered questionnaires
-
The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-12-26 Mansour Tobaiqy, Nawal Helmi, Katie MacLure, Sylvia Saade
-
Management of iron deficiency in women of childbearing age with oral iron intolerance: a prospective, randomised, controlled trial of three doses of an iron-whey-protein formulation Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-12-26 Mark Ledwidge, Fiona Ryan, Anna Seoighe, Maria Jose Santos-Martinez, Cristin Ryan, J. G. F. Gilmer
-
What do emergency department pharmacist practitioners know and understand about patient safeguarding? A qualitative study Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-12-19 Daniel Greenwood, Douglas Steinke, Sandra Martin, Gary Norton, Mary P. Tully
-
The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-12-19 Carlos Alves, Diogo Mendes, Ana Penedones, Tânia Oliveira, António Donato, Francisco Batel-Marques
-
Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-12-19 Rocío Díaz Acedo, Mercedes Galvan Banqueri, Silvia Artacho Criado, Eva María Fernández Parra, Rocío Jiménez Galán, Ana Isabel Gago Sánchez, Juan Francisco Marín Pozo, María José Martínez Bautista
-
Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-12-15 Wanlong Lin, Jiabing Xu, Yufang Liao, Xiuxian Lin, Jianhui Yang, Wei Zhuang
-
Bibliometric analysis of research trends and active research areas in chimeric antigen receptor T cell therapy for hematologic malignancies Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-12-12 Gaofeng Zhang, Lian Deng, Huirong Lu, Wenwen Zhang
-
Valproic acid for agitation in the intensive care unit: an observational study of psychiatric consults Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-12-10 Geneviève White, Noah Adessky, Fei-Wen Chen, Anne Regazzoni, Leon Tourian, Miguel Chagnon, Ashvini Gursahaney, Majed Alharbi, David Williamson, Marc M. Perreault
-
Scope, content and quality of clinical pharmacy practice guidelines: a systematic review Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-11-22 Vibhu Paudyal, Betul Okuyan, Martin Charles Henman, Derek Stewart, Daniela Fialová, Ankie Hazen, Monika Lutters, Anna Oleárová, Anita E. Weidmann, Francesca Wirth, Cathal A. Cadogan, Zachariah Nazar
-
Cost-effectiveness analysis of nivolumab versus placebo for relapsed malignant mesothelioma Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-11-22 Wenwang Lang, Jiarong Wei, Qinling Jiang, Qi Ai, Xianling Zhao, Liang Xiao, Yulong He
-
Managing delayed or missed pregabalin doses in patients with focal epilepsy: a Monte Carlo simulation study Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-11-22 Helin Xie, You Zheng, Chenyu Wang, Shiwei Song, Yihai Dai, Xian Huang, Maobai Liu, Xuemei Wu
-
Implementation of a national system for best practice delivery of paediatric infusions Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-11-16 Moninne M. Howlett, Sharon Sutton, Eimear L. McGrath, Cormac V. Breatnach
-
A quality improvement study of the implementation and initial results of a pragmatic clinical decision support system in the community pharmacy setting Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-11-14 Carolien Bogaerts, Nele Schoenmaekers, Marleen Haems, Michael Storme, Hans De Loof
-
A quality improvement study on the effect of electronic transmission of a basic discharge medication report on medication discrepancies in patients discharged from the hospital Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-11-07 Celine Koot, Marion Rook, Patricia A. M. Pols, Patricia M. L. A. van den Bemt, Matthijs L. Becker
-
A cross-sectional study examining the nature and extent of interprofessional education in schools of pharmacy in the United Kingdom Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-11-03 Clare Depasquale, Scott Cunningham, Sabrina Anne Jacob, Anne Boyter, Jane Portlock, Ailsa Power, Brian Addison
Background Interprofessional education can prepare the workforce for collaborative practice in complex health and social care systems. Aim To examine the nature and extent of interprofessional education in schools of pharmacy in the United Kingdom. Method An online questionnaire was developed using systems theory, published literature and input from an interprofessional expert panel; it included closed
-
How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-10-26 Nicolas Janus, Pierre-Yves Desplanques
-
Understanding general practitioners’ prescribing choices to patients with chronic low back pain: a discrete choice experiment Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-10-26 Melanie Hamilton, Chung-Wei Christine Lin, Sheena Arora, Mark Harrison, Marguerite Tracy, Brooke Nickel, Christina Abdel Shaheed, Danijela Gnjidic, Stephanie Mathieson
Background Although NSAIDs are recommended as a first line analgesic treatment, opioids are very commonly prescribed to patients with low back pain (LBP) despite risks of harms. Aim This study aimed to determine factors contributing to general practitioners’ (GPs’) prescribing choices to patients with chronic LBP in a primary care setting. Method This discrete choice experiment (DCE) presented 210
-
Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-10-16 Narumol Jarernsiripornkul, Somsak Tiamkao, Kamonphat Wongtaweepkij, Teekayu Plangkoon Jorns, Kanjana Junsuaydee, Nattakan Nontasen, Sasina Gayrash, Sirinya Kampichit
Background Anti-seizure drugs (ASDs) can potentially cause serious adverse drug reactions (ADRs). Patient self-reporting can increase the rate of ADR detection, but studies examining patient self-reporting of ADRs caused by ASDs are lacking. Aim To determine the characteristics of ADRs reported by patients receiving ASDs, assess laboratory data and medical record confirmation of patient-reported ADRs
-
A novel machine learning model to predict high on-treatment platelet reactivity on clopidogrel in Asian patients after percutaneous coronary intervention Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-10-10 Lan-Ping Ding, Ping Li, Li-Rong Yang, Mang-Mang Pan, Min Zhou, Chi Zhang, Yi-Dan Yan, Hou-Wen Lin, Xiao-Ye Li, Zhi-Chun Gu
-
Pharmacy student attitudes to mental illness and the provision of mental health care: a repeated cross-sectional survey Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-10-07 Dolores Keating, Stephen McWilliams, Mary Clarke, Judith Strawbridge
Background Attitudes to mental illness are an important factor in the willingness of professionals to engage in mental health care. Aim The aim of this study was to understand attitudes of undergraduate pharmacy students in Ireland to severe mental illness and the provision of medicines optimisation services as well as the variation in these attitudes throughout the undergraduate course. Method A survey
-
Opinions and experiences on the provision of care to people with mental illnesses: a qualitative study with Doctor of Pharmacy graduates after a rotation in psychiatry Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-10-05 Monica Zolezzi, Rawan Ghanem, Shahd Elamin, Yassin Eltorki
Background Pharmacists are vital to optimizing therapy of people with mental illnesses. Limited knowledge, lack of confidence, and mental health-related stigma can lead to pharmacists’ reluctance in the provision of pharmaceutical care to this population. Advanced pharmacy practice experiences (APPE) in mental health have been reported as valuable learning opportunities to overcome these challenges
-
Perinatal depression screening in community pharmacy: Exploring pharmacists’ roles, training and resource needs using content analysis Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-10-04 Clara Strowel, Camille Raynes-Greenow, Lily Pham, Stephen Carter, Katharine Birkness, Rebekah J. Moles, Claire L. O’Reilly, Timothy F. Chen, Corina Raduescu, Andrea Murphy, David Gardner, Sarira El-Den
Background Perinatal depression (PND) screening is often recommended in primary care settings, which includes the community pharmacy setting. However, there is limited research exploring pharmacists’ perspectives on their roles in screening for perinatal mental illness. Aim This study aimed to explore pharmacists’ views of pharmacists’ roles in PND screening, as well as training and resource needs
-
Overview of this issue: "clinical pharmacy impacting mental health delivery and outcomes". Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-10-01 Martina Hahn,Matej Stuhec,Filipa Alves da Costa
-
Environmental scan of current strategies to decrease sedative-hypnotic drug use and promote sleep in hospital patients Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-09-29 Heather L. Neville, Jenna Shaw, Carter VanIderstine, Sarah Burgess, Marci Dearing, Jennifer E. Isenor, Kent Toombs, Susan K. Bowles
-
A systematic review of quantitative studies exploring staff views on antipsychotic use in residents with dementia in care homes Int. J. Clin. Pharm. (IF 2.4) Pub Date : 2023-09-29 Amna Raza, Hannah Piekarz, Sundus Jawad, Tim Langran, Parastou Donyai